Pakhsh Hejrat Company
Pakhsh Hejrat Company
Pakhsh Hejrat Company is a listed pharmaceutical distribution company based in Tehran. In the Hormuz Group company graph, it matters because medicine availability depends not only on producers and importers but also on distributors with warehouse networks, cold-chain capability, pharmacy access, receivables management, and regulated logistics. Its IFB listing makes it useful for monitoring the economics of Iran's drug-distribution layer.
Products & Services
Pakhsh Hejrat Company distributes pharmaceutical products, imported and domestic medicines, supplements, medical equipment, laboratory products, hygienic and cosmetic products, strategic medicines, cold-chain items, and healthcare consumables. Its activity includes nationwide pharmaceutical logistics, warehousing, order fulfillment, sales to pharmacies and medical centers, import-related distribution, and distribution of medicines from domestic producers.
Investment Relevance
Pakhsh Hejrat is relevant for investors assessing Iran's pharmaceutical distribution sector, pharmacy supply, cold-chain logistics, medical-equipment distribution, medicine shortages, receivables from pharmacies and healthcare institutions, and the working-capital pressure created by regulated drug pricing. It can support analysis of distribution margins, inventory risk, import dependence, counterparty exposure, and the role of listed distributors in healthcare resilience. Due diligence should review updated Codal disclosures, IFB trading status, warehouse and branch network, customer concentration, supplier agreements, strategic-drug distribution rights, cold-chain controls, receivables aging, financing costs, regulatory compliance, and exposure to delayed payments or currency restrictions.
Connected Intelligence
This profile is connected to Hormuz taxonomy layers across geography, industry, market exposure, and investment constraints.
Source & Verification Note
Based on public company, official-company, pharmaceutical-distribution, medical-equipment, IFB/Codal disclosure, logistics, healthcare, and market-related information. Further verification is required before treating this profile as verified investment intelligence.